[go: up one dir, main page]

FR2691065B1 - Nouvelles compositions oculaires destinees a la prevention et au traitement de certains troubles de la vision. - Google Patents

Nouvelles compositions oculaires destinees a la prevention et au traitement de certains troubles de la vision.

Info

Publication number
FR2691065B1
FR2691065B1 FR9205979A FR9205979A FR2691065B1 FR 2691065 B1 FR2691065 B1 FR 2691065B1 FR 9205979 A FR9205979 A FR 9205979A FR 9205979 A FR9205979 A FR 9205979A FR 2691065 B1 FR2691065 B1 FR 2691065B1
Authority
FR
France
Prior art keywords
prevention
treatment
vision disorders
new eye
certain vision
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9205979A
Other languages
English (en)
Other versions
FR2691065A1 (fr
Inventor
Morelle Jean
Lauzanne Morelle Elianeas Jean
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR9205979A priority Critical patent/FR2691065B1/fr
Priority to PCT/FR1993/000473 priority patent/WO1993023028A1/fr
Priority to EP93910125A priority patent/EP0642339A1/fr
Publication of FR2691065A1 publication Critical patent/FR2691065A1/fr
Application granted granted Critical
Publication of FR2691065B1 publication Critical patent/FR2691065B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR9205979A 1992-05-18 1992-05-18 Nouvelles compositions oculaires destinees a la prevention et au traitement de certains troubles de la vision. Expired - Fee Related FR2691065B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9205979A FR2691065B1 (fr) 1992-05-18 1992-05-18 Nouvelles compositions oculaires destinees a la prevention et au traitement de certains troubles de la vision.
PCT/FR1993/000473 WO1993023028A1 (fr) 1992-05-18 1993-05-17 Compositions oculaires contenant de l'oleoylmethionine et de la dipalmitoylhydroxyproline
EP93910125A EP0642339A1 (fr) 1992-05-18 1993-05-17 Compositions oculaires contenant de l'oleoylmethionine et de la dipalmitoylhydroxyproline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9205979A FR2691065B1 (fr) 1992-05-18 1992-05-18 Nouvelles compositions oculaires destinees a la prevention et au traitement de certains troubles de la vision.

Publications (2)

Publication Number Publication Date
FR2691065A1 FR2691065A1 (fr) 1993-11-19
FR2691065B1 true FR2691065B1 (fr) 1994-07-29

Family

ID=9429865

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9205979A Expired - Fee Related FR2691065B1 (fr) 1992-05-18 1992-05-18 Nouvelles compositions oculaires destinees a la prevention et au traitement de certains troubles de la vision.

Country Status (3)

Country Link
EP (1) EP0642339A1 (fr)
FR (1) FR2691065B1 (fr)
WO (1) WO1993023028A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070020220A1 (en) 2005-04-27 2007-01-25 Procter & Gamble Personal care compositions
US9616011B2 (en) 2005-04-27 2017-04-11 The Procter & Gamble Company Personal care compositions
FR2890310B1 (fr) 2005-09-06 2009-04-03 Sederma Soc Par Actions Simpli Utilisation des protoberberines comme agents regulant l'activite de l'unite pilosebacee
ES2638242T3 (es) 2006-02-16 2017-10-19 Sederma Polipéptidos KXK y su uso
FR2900573B1 (fr) 2006-05-05 2014-05-16 Sederma Sa Nouvelles compositions cosmetiques renfermant au moins un peptide contenant au moins un cycle aromatique bloque
FR2939799B1 (fr) 2008-12-11 2011-03-11 Sederma Sa Composition cosmetique comprenant des oligoglucuronanes acetyles.
FR2941231B1 (fr) 2009-01-16 2016-04-01 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
FR2941232B1 (fr) 2009-01-16 2014-08-08 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
WO2010082177A2 (fr) 2009-01-16 2010-07-22 Sederma Nouveaux composés, notamment des peptides, compositions comprenant ces derniers et leurs utilisations dans les domaines cosmétique et dermopharmaceutique
FR2944435B1 (fr) 2009-04-17 2011-05-27 Sederma Sa Composition cosmetique comprenant de l'oridonine
FR2945939B1 (fr) 2009-05-26 2011-07-15 Sederma Sa Utilisation cosmetique du dipeptide tyr-arg pour lutter contre le relachement cutane.
JP2014524900A (ja) 2011-06-13 2014-09-25 ザ プロクター アンド ギャンブル カンパニー ｐＨ調整可能なゲル化剤を含むパーソナルケア組成物及び使用方法
CN103930167A (zh) 2011-06-13 2014-07-16 宝洁公司 包含二酰氨基胶凝剂的个人护理组合物和使用方法
EP2720666B1 (fr) 2011-06-20 2019-03-20 The Procter and Gamble Company Compositions de soin personnel comprenant des particules abrasives formées
US9271912B2 (en) 2012-06-13 2016-03-01 The Procter & Gamble Company Personal care compositions comprising a pH tuneable gellant and methods of using
CA3247205A1 (fr) 2022-03-31 2023-10-05 Galderma Holding SA Compositions de soins personnels pour peau sensible et procédés d'utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503153A1 (fr) * 1981-04-02 1982-10-08 Morelle Jean Butyrylaminoacides. mode de preparation. emploi dans les domaines cosmetique, hygienique, therapeutique et agricole
FR2654107B1 (fr) * 1989-11-03 1995-03-31 Jean Morelle Lipoaminoacides a chaines grasses insaturees non peroxydables.

Also Published As

Publication number Publication date
FR2691065A1 (fr) 1993-11-19
WO1993023028A1 (fr) 1993-11-25
EP0642339A1 (fr) 1995-03-15

Similar Documents

Publication Publication Date Title
FR2691065B1 (fr) Nouvelles compositions oculaires destinees a la prevention et au traitement de certains troubles de la vision.
EP0788359A4 (fr) Compositions utiles a la preparation de medicaments destines au traitement de divers troubles refractaires
ITRM910696A0 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
DE69109021D1 (de) Augentropfenarzneimittel.
IT8941653A0 (it) Dispositivo per la correzione delle anomalie di rifrazione dell'occhio.
FI953915A0 (fi) Dupuytrenin taudin lievittämiseen
FR2705966B1 (fr) Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
IL106521A0 (en) Pharmaceutical composition for the treatment or prevention of elevated intraocular pressure
HUP9900927A3 (en) Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
FR2678170B1 (fr) Compositions orales pour la prevention d'odontonecrose et de maladie paradentaire.
FR2712495B1 (fr) Application de l'Óoenotheine B pour obtenir un médicament destiné au traitement des troubles liés à l'hyperandrogénie, et les compositions pharmaceutiques le contenant.
EP0667157A4 (fr) Traitement symptomatique des troubles circulatoires.
FR2718024B1 (fr) Médicament et composition pharmaceutique pour le traitement de l'inflammation.
AU6678194A (en) Agents for the prevention and treatment of huntington's disease and other neurological disorders
EP0653208A3 (fr) Antagonistes de la substance P pour le traitement et la prévention de l'erythème solaire.
FR2732219B1 (fr) Compositions pharmaceutiques pour la prevention et le traitement du paludisme, a base d'un membre de la famille des chondroitine-glycosaminoglycanes
EP0979234A4 (fr) Procedes et compositions s'appliquant au diagnostique et au traitement des troubles neuropsychiatriques
EP0692965A4 (fr) Procede et composition s'appliquant au traitement de l'osteoporose
IL124730A0 (en) Compositions comprising bismuth and one or more antimicrobials for the prevention and treatment of gastrointestinal disorders
FR2757512B1 (fr) Utilisation de benzoylalkyl-1-1,2,3,6-tetrahydropyridines
FR2656529B3 (fr) Composition therapeutique destinee au traitement des troubles oculaires de l'accomodation.
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.
FR2707165B1 (fr) Application des taxoides au traitement de maladies d'origine parasitaire .
FR2698347B1 (fr) Nouvelles compositions pour le traitement de l'eau à base de glucoluryl et d'uréido hydrantoïne.

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse